• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 1

ACE Inhibitors: Medical Uses, Mechanisms of Action, Potential Adverse Effects & Related Topics -- Volume 1

9781634637015
535,44 zł
481,89 zł Zniżka 53,55 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 481,89 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book, published in two volumes, Volume 1 and Volume 2, respectively, represents the most comprehensive and up-to-date collection of current literature on angiotensin inhibition and related topics in medicine, nephrology and cardiovascular medicine ever compiled. Top experts in the various fields of nephrology, hypertension, cardiovascular medicine, pharmacotherapeutics and related fields from all five continents have contributed essays, original papers, reviews and editorial opinions to this volume. This book has turned out to be the most authoritative reference source on ACEIs, with contributions made by leading experts in their various fields of medicine, from the USA, Europe, including the United Kingdom, South America, Australia-New Zealand, Asia including Japan, and Africa. Critically vital clinical topics are covered in this book by top world-renowned experts in different subspecialties, including classic topics such as the efficacy of ACE inhibition as an antihypertensive among the various ethnicities and races, as written from American, African, Caribbean and European perspectives. This volume should indeed serve as a major literature reference text for physicians in general, internists, researchers, cardiologists and hypertension specialists, and especially the practitioners of the art of nephrology in all the countries around the world. Medical students and various physician training programs should reach for a copy of this volume as a research and teaching tool for many years to come. There is also a place here for research scientists in the pharmaceutical industry to review current and newly emerging indications for angiotensin inhibition and the future of reno-protection.
Szczegóły produktu
74793
9781634637015
9781634637015

Opis

Rok wydania
2015
Numer wydania
1
Oprawa
twarda
Liczba stron
264
Wymiary (mm)
180.00 x 260.00
Waga (g)
552
  • The Introduction of Angiotensin Converting Enzyme Inhibitors (ACEIs) & Angiotensin Receptor; RCTs Revisited:: A Nephrologists Critique of Randomized Controlled Trials in the Nephrology Literature; The Abuse of Renal Surrogates & Combination Renal Endpoints in Nephrology RCTs; The CKD Enigma, Reengineering CKD Care, Narrowing Asymmetric Information & Confronting Ethicomedicinomics in CKD Care:: The Introduction of The New CKD Express© IT Software Program; The Triple Whammy Challenge Revisited ACEIs, Diuretics & NSAIDs:: A European 21st Century Perspective; Quadruple Whammy:: A Newly Described Preventable Syndrome of Peri-Operative AKI on CKD in Patients on Concurrent Triple Whammy Medications; Late Onset Renal Failure from Angiotensin Blockade (LORFFAB) The Results of a Mayo Clinic Health System Angiotensin Inhibition Withdrawal Study:: A Clarion Call for More Preventative Nephrology, also Called Renoprevention; Acute Kidney Injury on Chronic Kidney Disease - The Rainbow Syndrome of Too Many Colors:: A Mayo Clinic Health System Case Series Report; The Syndrome of Rapid Onset ESRD in the Last 100 Consecutive Incident Northwestern Wisconsin Mayo Clinic Chronic Hemodialysis Patients, 2010-2011:: Results of the Analysis of Individual Patient-Level Serum Creatinine Trajectories to ESRD Can There be a L; Geriatric Nephrology Debate:: Angiotensin Inhibition Should be Withdrawn In Older Adults with Later Stage CKD:: A 2013 Mayo Clinic Health System Nephrologists Perspective & The Unmet Need For Newer Kidney-Friendly Renoprotective Agents For the 21st Century; Zofenopril:: A Sulphydryl ACE Inhibitor Endowed with Antioxidant & Cardioprotective Activity; Molecular Mechanisms & Pharmacological Implications of MMP-9 Inhibition by ACE Inhibitors; Hypertension & Angiotensin-Converting Enzyme Inhibitors in Rat Cardiac Microvessels:: A Mini Review of Histochemical Microvascular Studies; Action Mechanism of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Cowpea (Vigna unguiculata); Effect of Angiotensin-Converting Enzyme Inhibitors on Arterial Stiffness & Endothelial Dysfunction:: A Comprehensive Review; Index.
Komentarze (0)